Immune Profile and Prognosis of Malignant Liver Tumors With Radiofrequency Ablation (RFA) Therapy
NCT04707547
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
5
Enrollment
OTHER
Sponsor class
Conditions
Liver Cancer
Interventions
BIOLOGICAL:
immunotherapy with Nivolumab
PROCEDURE:
Radiofrequency Ablation
Sponsor
Taipei Medical University WanFang Hospital